The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cholestatic type of DILI is more prone to chronic injury and delayed recovery than other types and requires more time for recovery.
“In addition, evidence shows that the cholestatic type is more prone to the development of chronic injury and delayed recovery than other types and requires more time for recovery [21,73].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Self-citation
Flagged first, then by citations
Research works printed but not linked: 24
- Vuppalanchi, 2007, Etiology of new onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?, Am J Gastroenterol, 102, 558, 10.1111/j.1572-0241.2006.01019.x · DOI
- Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
- Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 · DOI
- Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- Aithal, 1999, The natural history of histologically proved drug-induced liver disease, Gut, 44, 731, 10.1136/gut.44.5.731 · DOI
- Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 1581, 10.1002/hep.21424 · DOI · Paper page
- Bjornsson, 2009, The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice, J Hepatol, 50, 511, 10.1016/j.jhep.2008.10.021 · DOI · Paper page
- Bjornosson, 2007, Long-term follow-up of patients with mild to moderate drug-induced liver injury, Aliment Pharmacol Ther, 26, 79, 10.1111/j.1365-2036.2007.03355.x · DOI
- Fontana, 2009, Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
- Chalasani, 2008, Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States, Gastroenterology, 135, 10.1053/j.gastro.2008.09.011 · DOI · Paper page
- Rockey, 2010, Causality assessment in drug induced liver injury using a structured expert opinion process: comparison to RUCAM, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
- Kamath, 2007, The Model for End-Stage Liver Disease (MELD), Hepatology, 45, 799, 10.1002/hep.21563 · DOI · Paper page
- Bjornosson, 2005, Outcome and prognostic markers in severe drug-induced liver disease, Hepatology, 42, 481, 10.1002/hep.20800 · DOI · Paper page
- Andrade, 2005, Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period, Gastroenterology, 1299, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- Russo, 2004, Liver transplantation for acute liver failure from drug induced liver injury in the United States, Liver Transpl, 10, 1018, 10.1002/lt.20204 · DOI · Paper page
- Younossi, 2004, Nonalcoholic fatty liver disease in patients with type 2 diabetes, Gastroenterology, 2, 262
- Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 10.1002/hep.21424 · DOI · Paper page
- Bjornsson, 2009, The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice, J Hepatol, 50, 511, 10.1016/j.jhep.2008.10.021 · DOI · Paper page
- Lucena, 2001, Comparison of two clinical scales for causality assessment in hepatotoxicity, Hepatology, 33, 123, 10.1053/jhep.2001.20645 · DOI · Paper page
- Navarro, 2013, Catechins in dietary supplements and hepatotoxicity, Dig Dis Sci, 58, 2682, 10.1007/s10620-013-2687-9 · DOI
- Davern, 2011, Role of acute hepatitis E in suspected drug-induced liver injury, Gastroenterology, 141, 1665, 10.1053/j.gastro.2011.07.051 · DOI
- Galan, 2005, The burden of acute nonfulminant drug induced hepatitis in a United States tertiary referral center, J Clin Gastroenterol, 39, 64
- Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin Gastroenterol Hepatol, 8, 463, 10.1016/j.cgh.2010.02.008 · DOI
- Hamer, 1999, Hypersensitivity syndrome to anti-epileptic drugs: a review including new anticonvulsants, Clev Clin J Med, 66, 239, 10.3949/ccjm.66.4.239 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Self-citationAndrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationReproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationDrug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10144-3 · Cited by 181
The Natural History of Severe Acute Liver Injury
Koch, D. G., Speiser, J. L., Durkalski, V, Fontana, R. J., Davern, T., McGuire, B., Stravitz, R. T., Larson, A. M., Liou, I., Fix, O., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.98 · Cited by 143
Self-citationChinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Mao, Y., Ma, S., Liu, C., Liu, X., Su, M., Li, D., Li, Y., Chen, G., Chen, J., Chen, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10633-7 · Cited by 62
Meyer, S. R., Zhang, C. J., Garcia, M. A., Procario, M. C., Yoo, S., Jolly, A. L., Kim, S., Kim, J., Baek, K., Kersten, R. D., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.08.004 · Cited by 35
Self-citationYeboah-Korang, A., Louissaint, J., Tsung, I., Prabhu, S., & Fontana, R. J. (2020) · Drug Safety · doi:10.1007/s40264-019-00903-5 · Cited by 15
Self-citationCharacteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types
Zhang, C., Wu, Y., Yuan, S., Dou, X., Sheng, Q., Wang, J., Tian, W., Yao, L., & Ding, Y. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-06030-6 · Cited by 6
Xiong, Y.-T., Wang, J.-F., Li, L., Bai, Z.-F., Liu, Y., Huang, A., Wang, K.-X., Fu, Y., Yang, W., Guo, C., et al. (2024) · iLIVER · doi:10.1016/j.iliver.2024.100095 · Cited by 6
Metadata
- Authors
- Fontana, R. J., Hayashi, P. H., Gu, J., Reddy, K. R., Barnhart, H., Watkins, P. B., Serrano, J., Lee, W. M., Chalasani, N., Stolz, A., Davern, T., & Talwakar, J. A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 147
- Issue
- 1
- Pages
- 96-108.e4
- ISSN
- 0016-5085
- PMC
- PMC4285559
- Cited by
- 218
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
